Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1991-04-30
1994-02-15
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424464, 424465, 424457, 424466, 424494, 424496, 424497, A61K 958, A61K 960, A61K 962, A61K 928
Patent
active
052864928
ABSTRACT:
A method for the treatment of gastrointestinal disorders associated with Helicobacter pylori infections which comprises administering to a patient an orally effective amount of triclosan is disclosed. The triclosan may be administered in the form of powders, granules, spheroids or liquids, or in unit dosage form as capsules or tablets containing 1 to 100 mg, preferably 10 to 60 mg, of triclosan. The triclosan may also be administered in gastric sustained release medicaments either as raft forming tablets or liquids, optionally to be co-administered with a solid pharmaceutically acceptable carboxylic acid or acid salt, or as mucoadherent-coated granules or spheroids.
REFERENCES:
Patent Abstracts of Japan, vol. 14, No. 126, Mar. 9, 1990.
Rauws et al., Gastroenterology, 1988, 94:33-40.
Vaira et al., Current Opinion in Gastroenterology, 1989, 5:817-823.
McNulty et al., Antimicrobial Agents and Chemotherapy, Dec. 1985, 28,6,837-838.
Dettmar Peter W.
Lloyd-Jones John G.
Levy N.
Page Thurman K.
Reckitt & Colman Products Limited
LandOfFree
Method of treatment of Heliobacter pylori infections with triclo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of Heliobacter pylori infections with triclo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of Heliobacter pylori infections with triclo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1205078